GPT-assisted radiomic modeling for predicting pathological complete response to neoadjuvant chemoimmunotherapy in head and neck squamous cell carcinoma.

Abstract

Objective. To evaluate whether GPT can assist in automating radiomics modeling for predicting pathological complete response to neoadjuvant chemoimmunotherapy in head and neck squamous cell carcinoma.Methods.The study included a training cohort (TC;n= 186), a validation cohort (VC;n= 116), and a prospective multicenter validation cohort (PVC;n= 269). Radiomic and supervised deep learning features were extracted from pretreatment T2-weighted magnetic resonance imaging. logistic regression (LR) was first evaluated using radiomic, deep learning, and fused features. Support vector machine, naïve Bayes, random forest, and extreme gradient boosting models were subsequently compared using fused features. GPT was not used as the classifier but assisted with preprocessing, feature selection, hyperparameter optimization, code generation and execution, model training, and probability output. Each GPT-assisted workflow was independently repeated five times.Results.Fused features achieved the highest area under the receiver operating characteristic curve for both manually developed and GPT-assisted LR models. Their AUCs were 0.759 versus 0.763 ± 0.003 in the TC, 0.714 versus 0.741 ± 0.008 in the VC, and 0.700 versus 0.706 ± 0.004 in the PVC. Across five classifiers, GPT-assisted workflows achieved performance broadly comparable to manually developed models. Repeated GPT-assisted runs showed limited variability, with AUC standard deviations ranging from 0.001 to 0.019.Conclusion.Under expert supervision, GPT can automate key radiomics modeling procedures while achieving performance comparable to conventional machine learning workflows, potentially reducing technical workload and facilitating integrated model development.